Statin-associated myopathy and the quest for biomarkers: can we effectively predict statin-associated muscle symptoms?

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081 · see citing works

Global estimates of diabetes prevalence for 2013 and projections for 2035

Guariguata, L., Whiting, D. R., Hambleton, I., Beagley, J., Linnenkamp, U., & Shaw, J. E. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.002 · Cited by 4,642 · see citing works

What are biomarkers?

Strimbu, K., & Tavel, J. A. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833ed177 · Cited by 2,062 · see citing works

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials

(2015) · The Lancet · doi:10.1016/s0140-6736(14)61368-4 · Cited by 1,536 · see citing works

Statin-associated myopathy

Thompson, P. D., Clarkson, P., & Karas, R. H. (2003) · JAMA · doi:10.1001/jama.289.13.1681 · Cited by 1,463 · see citing works

Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

Stroes, E. S., Thompson, P. D., Corsini, A., Vladutiu, G. D., Raal, F. J., Ray, K. K., Roden, M., Stein, E., Tokgözoğlu, L., Nordestgaard, B. G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv043 · Cited by 1,443 · see citing works

Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study

Bruckert, E., Hayem, G., Dejager, S., Yau, C., & Bégaud, B. (2005) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-005-5686-z · Cited by 1,226 · see citing works

ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins

Writing Committee Members:, Pasternak, R. C., Smith, S. C., Bairey-Merz, C. N., Grundy, S. M., Cleeman, J. I., & Lenfant, C. (2002) · Circulation · doi:10.1161/01.cir.0000032466.44170.44 · Cited by 1,088 · see citing works

The safety of statins in clinical practice

Armitage, J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60716-8 · Cited by 833 · see citing works

Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy

Mammen, A. L., Chung, T., Christopher‐Stine, L., Rosen, P., Rosen, A., Maurer, K. D., & Casciola-Rosen, L. A. (2010) · Arthritis & Rheumatism · doi:10.1002/art.30156 · Cited by 694 · see citing works

Statin Adverse Effects: A Review of the Literature and Evidence for a Mitochondrial Mechanism

Golomb, B. A., & Evans, M. A. (2008) · American Journal of Cardiovascular Drugs · doi:10.2165/0129784-200808060-00004 · Cited by 677 · see citing works

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment

HPS2-THRIVE Collaborative Group, Haynes, R., Jiang, L., Hopewell, J. C., Li, J., Chen, F., Parish, S., Landray, M. J., Collins, R., Armitage, J., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht055 · Cited by 676 · see citing works

Application of New Cholesterol Guidelines to a Population-Based Sample

Pencina, M. J., Navar‐Boggan, A. M., D’Agostino, R. B., Williams, K., Neely, B., Sniderman, A. D., & Peterson, E. D. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315665 · Cited by 612 · see citing works

Statin-associated myopathy with normal creatine kinase levels

Phillips, P. S., Haas, R. H., Bannykh, S., Hathaway, S., Gray, N. L., Kimura, B. J., Vladutiu, G. D., England, J. D. F., & and the Scripps Mercy Clinical Research Center* (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-7-200210010-00009 · Cited by 565 · see citing works

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised trial

Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group (2010) · The Lancet · doi:10.1016/s0140-6736(10)60310-8 · Cited by 558 · see citing works

Discontinuation of Statins in Routine Care Settings: A Cohort Study

Zhang, H., Plutzky, J., Skentzos, S., Morrison, F., Mar, P., Shubina, M., & Turchin, A. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-7-201304020-00004 · Cited by 548 · see citing works

The Role of Coenzyme Q10 in Statin-Associated Myopathy

Marcoff, L., & Thompson, P. D. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.049 · Cited by 537 · see citing works

Effect of statins on skeletal muscle function

Parker, B. A., Capizzi, J. A., Grimaldi, A. S., Clarkson, P. M., Cole, S. M., Keadle, J., Chipkin, S., Pescatello, L. S., Simpson, K., White, C. M., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.136101 · Cited by 500 · see citing works

Understanding statin use in America and gaps in patient education (USAGE): an internet-based survey of 10,138 current and former statin users

Cohen, J. D., Brinton, E. A., Ito, M. K., & Jacobson, T. A. (2012) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2012.03.003 · Cited by 486 · see citing works

An assessment by the statin muscle safety task force: 2014 update

Rosenson, R. S., Baker, S. K., Jacobson, T. A., Kopecky, S. L., & Parker, B. A. (2014) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2014.03.004 · Cited by 485 · see citing works

Narrative review: statin-related myopathy

Joy, T. R., & Hegele, R. A. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-12-200906160-00009 · Cited by 453 · see citing works

Mitochondrial quality control and muscle mass maintenance.

Romanello, V., & Sandri, M. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2015.00422 · Cited by 434 · see citing works

Position paper Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel

Banach, M., Rizzo, M., Toth, P. P., Farnier, M., Davidson, M. H., Al‐Rasadi, K., Aronow, W. S., Athyros, V. G., Djuric, D. M., Владиславович, Е. М., et al. (2015) · Archives of Medical Science · doi:10.5114/aoms.2015.49807 · Cited by 381 · see citing works

The Bioenergetic Health Index: a new concept in mitochondrial translational research

Chacko, B., Kramer, P. A., Ravi, S., Benavides, G., Mitchell, T., Dranka, B. P., Ferrick, D., Singal, A., Ballinger, S., Bailey, S., et al. (2014) · Clinical science · doi:10.1042/cs20140101 · Cited by 342 · see citing works

Mitochondria as a Therapeutic Target in Heart Failure

Bayeva, M., Gheorghiade, M., & Ardehali, H. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.1021 · Cited by 336 · see citing works

The metabolic regulation of aging

Finkel, T. (2015) · Nature Medicine · doi:10.1038/nm.3998 · Cited by 325 · see citing works

Statin-induced myopathy: a review and update

Abd, T. T., & Jacobson, T. A. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.540568 · Cited by 320 · see citing works

High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial

PAIVA, H., THELEN, K., COSTER, R., SMET, J., PAEPE, B., MATTILA, K., LAAKSO, J., LEHTIMAKI, T., VONBERGMANN, K., & LUTJOHANN, D. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.03.006 · Cited by 308 · see citing works

The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011

Ray, K. K., Kastelein, J. J. P., Boekholdt, S. M., Nicholls, S. J., Khaw, K., Ballantyne, C. M., Catapano, A. L., Reiner, E., & Lüscher, T. F. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu107 · Cited by 304 · see citing works

The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity

Hanai, J., Cao, P., Tanksale, P., Imamura, S., Koshimizu, E., Zhao, J., Kishi, S., Yamashita, M., Phillips, P. S., Sukhatme, V. P., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32741 · Cited by 281 · see citing works

Peroxisome Proliferator–Activated Receptor γ Coactivator-1 (PGC-1) Regulatory Cascade in Cardiac Physiology and Disease

Finck, B. N., & Kelly, D. P. (2007) · Circulation · doi:10.1161/circulationaha.107.670588 · Cited by 281 · see citing works

Prescription cholesterol-lowering medication use in adults aged 40 and over: United States, 2003-2012.

Gu, Q., Paulose‐Ram, R., Burt, V. L., & Kit, B. K. (2014) · PubMed · Cited by 265 · see citing works

An Assessment of Statin Safety by Muscle Experts

Thompson, P. D., Clarkson, P. M., & Rosenson, R. S. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.013 · Cited by 263 · see citing works

Toxicity of statins on rat skeletal muscle mitochondria

Kaufmann, P., Török, M., Zahno, A., Waldhauser, K. M., Brecht, K., & Krähenbühl, S. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6235-z · Cited by 263 · see citing works

Lipid‐lowering drugs and mitochondrial function: effects of HMG‐CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio

DE PINIEUX, G., CHARIOT, P., AMMI‐SAÏD, M., LOUARN, F., LEJONC, J. L., ASTIER, A., JACOTOT, B., & GHERARDI, R. (1996) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1996.04178.x · Cited by 262 · see citing works

Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a ‘mitohormesis’ mechanism involving reactive oxygen species and PGC-1

Bouitbir, J., Charles, A.-L., Echaniz-Laguna, A., Kindo, M., Daussin, F., Auwerx, J., Piquard, F., Geny, B., & Zoll, J. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr224 · Cited by 256 · see citing works

Predictors of statin adherence, switching, and discontinuation in the USAGE survey: Understanding the use of statins in America and gaps in patient education

Wei, M. Y., Ito, M. K., Cohen, J. D., Brinton, E. A., & Jacobson, T. A. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.03.001 · Cited by 254 · see citing works

A systematic review of statin-induced muscle problems in clinical trials

Ganga, H. V., Slim, H. B., & Thompson, P. D. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.03.019 · Cited by 253 · see citing works

Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016)

Mancini, G. B. J., Baker, S. K., Bergeron, J., FITCHETT, D. H., Frohlich, J. J., Genest, J. J., Gupta, M., Hegele, R. A., Ng, D. S., Pearson, G. J., et al. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.01.003 · Cited by 253 · see citing works

Statin-induced apoptosis and skeletal myopathy

Dirks, A. J., & Jones, K. M. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00226.2006 · Cited by 240 · see citing works

Statin-Induced Myopathy Is Associated with Mitochondrial Complex III Inhibition

Schirris, T. J. J., Renkema, G. H., Ritschel, T., Voermans, N. C., Bilos, A., van Engelen, B. G. M., Brandt, U., Koopman, W. J. H., Beyrath, J., Rodenburg, R. J., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.08.002 · Cited by 227 · see citing works

Muscle function and fat content in relation to sarcopenia, obesity and frailty of old age — An overview

Buch, A., Carmeli, E., Boker, L. K., Marcus, Y., Shefer, G., Kis, O., Berner, Y., & Stern, N. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.01.008 · Cited by 227 · see citing works

Resistance and intolerance to statins

Reiner, Ž. (2014) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.05.009 · Cited by 225 · see citing works

A Systems Biology Strategy Reveals Biological Pathways and Plasma Biomarker Candidates for Potentially Toxic Statin-Induced Changes in Muscle

Laaksonen, R., Katajamaa, M., Päivä, H., Sysi‐Aho, M., Saarinen, L., Junni, P., Lütjohann, D., Smet, J., Coster, R. V., Seppänen‐Laakso, T., et al. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000097 · Cited by 223 · see citing works

Phenotype standardization for statin-induced myotoxicity

Alfirevic, A., Neely, D., Armitage, J., Chinoy, H., Cooper, R. G., Laaksonen, R., Carr, D. F., Bloch, K. M., Fahy, J., Hanson, A., et al. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.121 · Cited by 220 · see citing works

Statin-Induced Muscle Necrosis in the Rat: Distribution, Development, and Fibre Selectivity

Westwood, F. R., Bigley, A. L., Randall, K., Marsden, A. M., & Scott, R. C. (2005) · Toxicologic Pathology · doi:10.1080/01926230590908213 · Cited by 212 · see citing works

Large-scale chemical dissection of mitochondrial function

Wagner, B. K., Kitami, T., Gilbert, T. J., Peck, D., Ramanathan, A., Schreiber, S. L., Golub, T. R., & Mootha, V. K. (2008) · Nature Biotechnology · doi:10.1038/nbt1387 · Cited by 205 · see citing works

Complications of Diabetes

Papatheodorou, K., Banach, M., EDMONDS, M. E., Παπάνας, Ν., & Papazoglou, D. (2015) · Journal of Diabetes Research · doi:10.1155/2015/189525 · Cited by 203 · see citing works

Effects of Coenzyme Q10 on Statin-Induced Myopathy

Banach, M., Serban, C., Sahebkar, A., Ursoniu, S., Rysz, J., Muntner, P., Toth, P. P., Jones, S. R., Rizzo, M., Glasser, S. P., et al. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.08.021 · Cited by 198 · see citing works

Statin therapy and plasma coenzyme Q10 concentrations—A systematic review and meta-analysis of placebo-controlled trials

Banach, M., Serban, C., Ursoniu, S., Rysz, J., Muntner, P., Toth, P. P., Jones, S. R., Rizzo, M., Glasser, S. P., Watts, G. F., et al. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.07.008 · Cited by 195 · see citing works

Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients

Nichols, G. A., & Koro, C. E. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.08.022 · Cited by 173 · see citing works

Sarcopenia and frailty in older patients with diabetes mellitus

Umegaki, H. (2016) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12688 · Cited by 168 · see citing works

Association between statin-associated myopathy and skeletal muscle damage

Mohaupt, M. G., Karas, R. H., Babiychuk, E. B., Sanchez-Freire, V., Monastyrskaya, K., Iyer, L., Hoppeler, H., Breil, F., & Draeger, A. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.081785 · Cited by 166 · see citing works

An assessment by the Statin Intolerance Panel: 2014 update

Guyton, J. R., Bays, H. E., Grundy, S. M., & Jacobson, T. A. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.03.002 · Cited by 165 · see citing works

Simvastatin Effects on Skeletal Muscle

Larsen, S., Stride, N., Hey-Mogensen, M., Hansen, C. N., Bang, L. E., Bundgaard, H., Nielsen, L. B., Helge, J. W., & Dela, F. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.036 · Cited by 165 · see citing works

Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia

Draeger, A., Monastyrskaya, K., Mohaupt, M., Hoppeler, H., Savolainen, H., Allemann, C., & Babiychuk, E. (2006) · The Journal of Pathology · doi:10.1002/path.2018 · Cited by 163 · see citing works

Simvastatin triggers mitochondria-induced Ca2+ signaling alteration in skeletal muscle

Sirvent, P., Mercier, J., Vassort, G., & Lacampagne, A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.070 · Cited by 154 · see citing works

The role of mitochondria in statin‐induced myopathy

Apostolopoulou, M., Corsini, A., & Roden, M. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12461 · Cited by 142 · see citing works

Inhibition of Cholesterol Synthesis by Squalene Synthase Inhibitors Does Not Induce Myotoxicityin Vitro

Flint, O. P., Masters, B. A., Gregg, R. E., & Durham, S. K. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1997.8131 · Cited by 132 · see citing works

Effects of Lipid-Lowering Drugs on Irisin in Human Subjects In Vivo and in Human Skeletal Muscle Cells Ex Vivo

Gouni‐Berthold, I., Berthold, H. K., Huh, J. Y., Berman, R., Spenrath, N., Krone, W., & Mantzoros, C. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072858 · Cited by 132 · see citing works

Blunted Akt/FOXO signalling and activation of genes controlling atrophy and fuel use in statin myopathy

Mallinson, J. E., Constantin‐Teodosiu, D., Sidaway, J. E., Westwood, F. R., & Greenhaff, P. L. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.164699 · Cited by 119 · see citing works

Statin‐induced muscle damage and atrogin‐1 induction is the result of a geranylgeranylation defect

Cao, P., Hanai, J., Tanksale, P., Imamura, S., Sukhatme, V. P., & Lecker, S. H. (2009) · The FASEB Journal · doi:10.1096/fj.08-128843 · Cited by 118 · see citing works

Myopathy Induced by HMG–CoA Reductase Inhibitors in Rabbits: A Pathological, Electrophysiological, and Biochemical Study

Nakahara, K., Kuriyama, M., Sonoda, Y., Yoshidome, H., Nakagawa, H., Fujiyama, J., Higuchi, I., & Osame, M. (1998) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1998.8491 · Cited by 116 · see citing works

Simvastatin induces impairment in skeletal muscle while heart is protected

Sirvent, P., Bordenave, S., Vermaelen, M., Roels, B., Vassort, G., Mercier, J., Raynaud, E., & Lacampagne, A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.108 · Cited by 116 · see citing works

Simvastatin impairs ADP-stimulated respiration and increases mitochondrial oxidative stress in primary human skeletal myotubes

Kwak, H.-B., Thalacker-Mercer, A., Anderson, E. J., Lin, C.-T., Kane, D. A., Lee, N.-S., Cortright, R. N., Bamman, M. M., & Neufer, P. D. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.449 · Cited by 114 · see citing works

Effects of Statins on Skeletal Muscle: A Perspective for Physical Therapists

Stasi, S. L. D., MacLeod, T. D., Winters, J. D., & Binder‐Macleod, S. A. (2010) · Physical Therapy · doi:10.2522/ptj.20090251 · Cited by 114 · see citing works

Molecular basis of statin-associated myopathy

Vaklavas, C., Chatzizisis, Y. S., Ziakas, A., Zamboulis, C., & Giannoglou, G. D. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.05.021 · Cited by 114 · see citing works

Weighing the benefits of high-dose simvastatin against the risk of myopathy

Egan, A., & Colman, E. (2011) · New England Journal of Medicine · doi:10.1056/nejmp1106689 · Cited by 113 · see citing works

Mechanisms and assessment of statin‐related muscular adverse effects

Moßhammer, D., Schaeffeler, E., Schwab, M. G., & Mörike, K. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12360 · Cited by 110 · see citing works

Relation of mitochondrial oxygen consumption in peripheral blood mononuclear cells to vascular function in type 2 diabetes mellitus

Hartman, M.-L., Shirihai, O. S., HOLBROOK, M. M., Xu, G., Kocherla, M., Shah, A. K., Fetterman, J. L., Kluge, M. A., Frame, A. A., Hamburg, N. M., et al. (2014) · Vascular Medicine · doi:10.1177/1358863x14521315 · Cited by 109 · see citing works

Screening for Statin-Related Toxicity

Smith, C. C., Bernstein, L. I., Davis, R. B., Rind, D. M., & Shmerling, R. H. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.6.688 · Cited by 108 · see citing works

Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies

Colantonio, L. D., Bittner, V., Reynolds, K., Levitan, E. B., Rosenson, R. S., Banach, M., Kent, S. T., Derose, S. F., Zhou, H., Safford, M. M., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.011646 · Cited by 105 · see citing works

Reductive stress impairs myoblasts mitochondrial function and triggers mitochondrial hormesis

Singh, F., Charles, A., Schlagowski, A.-I., Bouitbir, J., Bonifacio, A., Piquard, F., Krähenbühl, S., Gény, B., & Zoll, J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.03.006 · Cited by 104 · see citing works

Effect of Statins on Creatine Kinase Levels Before and After a Marathon Run

Parker, B. A., Augeri, A. L., Capizzi, J. A., Ballard, K. D., Troyanos, C., Baggish, A. L., d’Hemecourt, P. A., & Thompson, P. D. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.08.045 · Cited by 98 · see citing works

Statins Trigger Mitochondrial Reactive Oxygen Species-Induced Apoptosis in Glycolytic Skeletal Muscle

Bouitbir, J., Singh, F., Charles, A., Schlagowski, A.-I., Bonifacio, A., Echaniz‐Laguna, A., Gény, B., Krähenbühl, S., & Zoll, J. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6190 · Cited by 95 · see citing works

The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy

Chung, T., Christopher-Stine, L., Paik, J., Corse, A., & Mammen, A. (2015) · Muscle and Nerve · doi:10.1002/mus.24642 · Cited by 93 · see citing works

Statin myopathy: Incidence, risk factors, and pathophysiology

Sewright, K. A., Clarkson, P. M., & Thompson, P. D. (2007) · Current Atherosclerosis Reports · doi:10.1007/s11883-007-0050-3 · Cited by 90 · see citing works

Statin Induced Myopathy and Myalgia: Time Trend Analysis and Comparison of Risk Associated with Statin Class from 1991–2006

Molokhia, M., McKeigue, P., Ćurčin, V., & Majeed, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002522 · Cited by 85 · see citing works

Drug–drug interactions that interfere with statin metabolism

Hirota, T., & Ieiri, I. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1056149 · Cited by 84 · see citing works

Statins as a possible cause of inflammatory and necrotizing myopathies

Padala, S. K., & Thompson, P. D. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.11.005 · Cited by 81 · see citing works

Variability in microRNA recovery from plasma: Comparison of five commercial kits

Brunet‐Vega, A., Pericay, C., Quílez, M. E., Ramírez‐Lázaro, M. J., Calvet, X., & Lario, S. (2015) · Analytical Biochemistry · doi:10.1016/j.ab.2015.07.018 · Cited by 77 · see citing works

Irisin, a unique non-inflammatory myokine in stimulating skeletal muscle metabolism

Vaughan, R. A., Gannon, N. P., Mermier, C. M., & Conn, C. A. (2015) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-015-0433-9 · Cited by 77 · see citing works

Comparing myotoxic effects of squalene synthase inhibitor, T-91485, and 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in human myocytes

Nishimoto, T., Tozawa, R., Amano, Y., Wada, T., Imura, Y., & Sugiyama, Y. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.08.011 · Cited by 76 · see citing works

Needed: Pragmatic Clinical Trials for Statin-Intolerant Patients

Maningat, P. D., & Breslow, J. L. (2011) · New England Journal of Medicine · doi:10.1056/nejmp1112023 · Cited by 74 · see citing works

The Bioenergetic Health Index is a sensitive measure of oxidative stress in human monocytes

Chacko, B. K., Zhi, D., Darley-Usmar, V. M., & Mitchell, T. (2015) · Redox Biology · doi:10.1016/j.redox.2015.12.008 · Cited by 74 · see citing works

Peroxisomal protein targeting and identification of peroxisomal targeting signals in cholesterol biosynthetic enzymes

Olivier, L. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00139-6 · Cited by 73 · see citing works

Lapaquistat Acetate

Stein, E. A., Bays, H. E., O’Brien, D., Pedicano, J., Piper, E., & Spezzi, A. (2011) · Circulation · doi:10.1161/circulationaha.110.975284 · Cited by 70 · see citing works

Structural and functional characterization of simvastatin-induced myotoxicity in different skeletal muscles

Özek, N. Ş., Bal, I. B., Sara, Y., Onur, R., & Severcan, F. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.09.010 · Cited by 69 · see citing works

Impact of Statin Dosing Intensity on Transaminase and Creatine Kinase

Dale, K. M., White, C. M., Henyan, N. N., Kluger, J., & Coleman, C. I. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.07.033 · Cited by 69 · see citing works

Contribution of mitochondrial oxidative stress to hypertension

Dikalov, S., & Dikalova, A. (2015) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000198 · Cited by 69 · see citing works

Evaluation of the usefulness of biomarkers for cardiac and skeletal myotoxicity in rats

Tonomura, Y., Mori, Y., Torii, M., & Uehara, T. (2009) · Toxicology · doi:10.1016/j.tox.2009.10.014 · Cited by 66 · see citing works

Biomarker panel of cardiac and skeletal muscle troponins, fatty acid binding protein 3 and myosin light chain 3 for the accurate diagnosis of cardiotoxicity and musculoskeletal toxicity in rats

Tonomura, Y., Matsushima, S., Kashiwagi, E., Fujisawa, K., Takagi, S., Nishimura, Y., Fukushima, R., Torii, M., & Matsubara, M. (2012) · Toxicology · doi:10.1016/j.tox.2012.07.012 · Cited by 63 · see citing works

Evaluation of skeletal muscle during calf exercise by 31-phosphorus magnetic resonance spectroscopy in patients on statin medications

Wu, J. S., Buettner, C., Smithline, H., Ngo, L. H., & Greenman, R. L. (2011) · Muscle & Nerve · doi:10.1002/mus.21847 · Cited by 61 · see citing works

Identification of 1- and 3-methylhistidine as biomarkers of skeletal muscle toxicity by nuclear magnetic resonance-based metabolic profiling

Aranı́bar, N., Vassallo, J. D., Rathmacher, J. A., Stryker, S. A., Zhang, Y., Dai, J., Janovitz, E. B., Robertson, D., Reily, M. D., Lowe‐Krentz, L. J., et al. (2010) · Analytical Biochemistry · doi:10.1016/j.ab.2010.11.023 · Cited by 60 · see citing works

Statin myotoxicity is associated with changes in the cardiopulmonary function

Phillips, P. S., Phillips, C. T., Sullivan, M. J., Naviaux, R. K., & Haas, R. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.06.014 · Cited by 59 · see citing works

Statin Lactonization by Uridine 5′-Diphospho-glucuronosyltransferases (UGTs)

Schirris, T. J. J., Ritschel, T., Bilos, A., Smeitink, J. A. M., & Rüssel, F. G. M. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00474 · Cited by 58 · see citing works

Simvastatin may induce insulin resistance through a novel fatty acid mediated cholesterol independent mechanism

Kain, V., Kapadia, B. B., Misra, P., & Saxena, U. (2015) · Scientific Reports · doi:10.1038/srep13823 · Cited by 57 · see citing works

Lipids, blood pressure and kidney update 2015

Banach, M., Aronow, W. S., Șerban, M.-C., Rysz, J., Voroneanu, L. E., & Covic, A. C. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0169-0 · Cited by 57 · see citing works

Statin myopathy as a metabolic muscle disease

Phillips, P. S., & Haas, R. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.7.971 · Cited by 56 · see citing works

Effect of a high dose of simvastatin on muscle mitochondrial metabolism and calcium signaling in healthy volunteers

Galtier, F., Mura, T., de Mauverger, É. R., Chevassus, H., Farret, A., Gagnol, J., Costa, F., Dupuy, A., Petit, P., Cristol, J., et al. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.06.020 · Cited by 55 · see citing works

The impact of statins on biological characteristics of stem cells provides a novel explanation for their pleiotropic beneficial and adverse clinical effects

Izadpanah, R., Schächtele, D. J., Pfnür, A., Lin, D., Slakey, D. P., Kadowitz, P. J., & Alt, E. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00406.2014 · Cited by 54 · see citing works

Involvement of organic anion transporting polypeptides in the toxicity of hydrophilic pravastatin and lipophilic fluvastatin in rat skeletal myofibres

Sakamoto, K., Mikami, H., & Kimura, J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.192 · Cited by 53 · see citing works

The creatine kinase response to eccentric exercise with atorvastatin 10 mg or 80 mg

Kearns, A. K., Bilbie, C., Clarkson, P. M., White, C. M., Sewright, K. A., O’Fallon, K. S., Gadarla, M., & Thompson, P. D. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.12.029 · Cited by 53 · see citing works

Underappreciated Statin-Induced Myopathic Weakness Causes Disability

Dobkin, B. H. (2005) · Neurorehabilitation and neural repair · doi:10.1177/1545968305277167 · Cited by 48 · see citing works

Mitochondrial alterations in muscle biopsies of patients on statin therapy.

Gambelli, S., Dotti, M. T., Malandrini, A., Mondelli, M. U., Stromillo, M. L., Gaudiano, C., & Federico, A. (2004) · PubMed · Cited by 46 · see citing works

Evaluation of the Relative Performance of Drug-Induced Skeletal Muscle Injury Biomarkers in Rats

Burch, P. M., Hall, D. G., Walker, E. G., Bracken, W. M., Giovanelli, R. P., Goldstein, R., Higgs, R. E., King, N. M. P., Lane, P., Sauer, J., et al. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv328 · Cited by 46 · see citing works

Statins impair glucose uptake in human cells

Nowis, D., Malenda, A., Furs, K., Oleszczak, B., Sadowski, R., Chlebowska, J., Firczuk, M., Bujnicki, J. M., Staruch, A. D., Zagożdżon, R., et al. (2014) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2014-000017 · Cited by 45 · see citing works

Influence of statins on distinct circulating microRNAs during prolonged aerobic exercise

Min, P., Park, J., Isaacs, S. K., Taylor, B. A., Thompson, P. D., Troyanos, C., d’Hemecourt, P. A., Dyer, S., Chan, S. Y., & Baggish, A. L. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00654.2015 · Cited by 44 · see citing works

HMG-CoA reductase inhibitors perturb fatty acid metabolism and induce peroxisomes in keratinocytes.

Williams, M. L., Menon, G., & Hanley, K. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41539-1 · Cited by 44 · see citing works

Increases in creatine kinase with atorvastatin treatment are not associated with decreases in muscular performance

Ballard, K. D., Parker, B. A., Capizzi, J. A., Grimaldi, A. S., Clarkson, P. M., Cole, S. M., Keadle, J., Chipkin, S. R., Pescatello, L. S., Simpson, K., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.07.001 · Cited by 42 · see citing works

Statin Therapy and the Expression of Genes that Regulate Calcium Homeostasis and Membrane Repair in Skeletal Muscle

Draeger, A., Sánchez-Freire, V., Monastyrskaya, K., Hoppeler, H. H., Mueller, M., Breil, F., Mohaupt, M. G., & Babiychuk, E. B. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091140 · Cited by 40 · see citing works

Evaluation of microRNAs−208 and 133a/b as differential biomarkers of acute cardiac and skeletal muscle toxicity in rats

Calvano, J. E., Achanzar, W. E., Murphy, B., DiPiero, J., Hixson, C. J., Parrula, C., Burr, H., Mangipudy, R. S., & Tirmenstein, M. A. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.11.015 · Cited by 40 · see citing works

3‐hydroxy 3‐methylglutaryl coenzyme a reductase inhibition impairs muscle regeneration

Trapani, L., Segatto, M., Rosa, P. L., Fanelli, F., Moreno, S., Marino, M., & Pallottini, V. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24077 · Cited by 39 · see citing works

Genetic and immunologic susceptibility to statin-related myopathy

Patel, J., Superko, H. R., Martin, S. S., Blumenthal, R. S., & Christopher‐Stine, L. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.03.025 · Cited by 38 · see citing works

Statin-Induced Increases in Atrophy Gene Expression Occur Independently of Changes in PGC1α Protein and Mitochondrial Content

Goodman, C. A., Derk, P., Zacharewicz, E., Lee, R. S., Snow, R. J., Russell, A. P., & McConell, G. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128398 · Cited by 35 · see citing works

The Interaction Between Statins and Exercise: Mechanisms and Strategies to Counter the Musculoskeletal Side Effects of This Combination Therapy.

Deichmann, R. E., Lavie, C. J., Asher, T., DiNicolantonio, J. J., O’Keefe, J. H., & Thompson, P. D. (2015) · Europe PMC (PubMed Central) · Cited by 35 · see citing works

Targeting skeletal muscle mitochondria to prevent type 2 diabetes in youth

Gordon, J. W., Dolinsky, V. W., Mughal, W., Gordon, G. R., & McGavock, J. (2015) · Biochemistry and Cell Biology · doi:10.1139/bcb-2015-0012 · Cited by 30 · see citing works

Addressing Statin Adverse Effects in the Clinic

Katz, D. H., Intwala, S., & Stone, N. (2014) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248414529622 · Cited by 27 · see citing works

Statin-associated Autoimmune Myopathies: A Pathophysiologic Spectrum

Wu, Y. F., Lach, B., Provias, J., Tarnopolsky, M. A., & Baker, S. K. (2014) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2014.22 · Cited by 26 · see citing works

Pleiotropic effects of statins in hypercholesterolaemia: a prospective observational study using a lipoproteomic based approach

Bhandari, S., Gupta, P., Quinn, P. A., Sandhu, J. K., Hakimi, A., Jones, D. J. L., & Ng, L. L. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60336-1 · Cited by 23 · see citing works

Statin Discontinuation and Intolerance: The Challenge of Lifelong Therapy

Grundy, S. M. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-7-201304020-00010 · Cited by 21 · see citing works

Elevated skeletal muscle phosphodiesters in adults using statin medications

Slade, J. M., DeLano, M. C., & Meyer, R. A. (2006) · Muscle & Nerve · doi:10.1002/mus.20619 · Cited by 21 · see citing works

Skeletal muscle ultrastructure and function in statin-tolerant individuals

Rengo, J. L., Callahan, D. M., Savage, P. D., Ades, P. A., & Toth, M. J. (2015) · Muscle & Nerve · doi:10.1002/mus.24722 · Cited by 21 · see citing works

Annexin A1 is a biomarker of T‐tubular repair in skeletal muscle of nonmyopathic patients undergoing statin therapy

Voigt, T., Sebald, H., Schoenauer, R., Levano, S., Girard, T., Hoppeler, H. H., Babiychuk, E. B., & Draeger, A. (2013) · The FASEB Journal · doi:10.1096/fj.12-219345 · Cited by 18 · see citing works

The Risk for Significant Creatine Kinase Elevation with Statins

Stolcpart, R. S., Olson, K. L., Delate, T., Rasmussen, J. R., Rehring, T. F., & Merenich, J. A. (2010) · American Journal of Cardiovascular Drugs · doi:10.2165/11536130-000000000-00000 · Cited by 16 · see citing works

Primary Prevention of Atherosclerotic Cardiovascular Disease

Newsom, L. C. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014564181 · Cited by 12 · see citing works

Evidence for metabolic aberrations in asymptomatic persons with type 2 diabetes after initiation of simvastatin therapy

Suneja, M., Fox, D. K., Fink, B. D., Herlein, J. A., Adams, C. M., & Sivitz, W. I. (2015) · Translational research · doi:10.1016/j.trsl.2015.01.007 · Cited by 7 · see citing works

STOMPing forward: Statins, muscle complaints and CK

Laaksonen, R. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.07.044 · Cited by 6 · see citing works

Application of New Cholesterol Guidelines to the Korean Adult Diabetic Patients

Kim, B. K., Kim, H. C., Ha, K. H., & Kim, D. J. (2015) · Journal of Korean Medical Science · doi:10.3346/jkms.2015.30.11.1612 · Cited by 5 · see citing works

The enigmatic illness and death of Constance, wife of Oscar Wilde

Robins, A. H., & Holland, M. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62468-5 · Cited by 3 · see citing works

Is Myopathy the Achilles' Heel of Statins?

Rallidis, L. S., & ANASTASIOU‐NANA, M. I. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.12.047 · Cited by 2 · see citing works

Statin Toxicity

Ward, N. C., Watts, G. F., & Eckel, R. H. (2019) · Circulation Research · doi:10.1161/circresaha.118.312782 · Cited by 772 · see citing works

The Role of Nutraceuticals in Statin Intolerant Patients

Banach, M., Patti, A. M., Giglio, R. V., Cicero, A. F. G., Atanasov, A. G., Bajraktari, G., Bruckert, E., Descamps, O., Djuric, D. M., Ezhov, M., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.040 · Cited by 272 · see citing works

Hydrophilic or Lipophilic Statins?

Climent, E., Benaiges, D., & Pedro‐Botet, J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.687585 · Cited by 252 · see citing works

Management of Statin Intolerance in 2018: Still More Questions Than Answers

Toth, P. P., Patti, A. M., Giglio, R. V., Nikolić, D., Castellino, G., Rizzo, M., & Banach, M. (2018) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-017-0259-7 · Cited by 188 · see citing works

Myotoxicity of statins: Mechanism of action

du Souich, P., Roederer, G. O., & Dufour, R. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.029 · Cited by 162 · see citing works

Statins Neuromuscular Adverse Effects

Attardo, S., Musumeci, O., Velardo, D., & Toscano, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158364 · Cited by 114 · see citing works

The Role of Structure and Biophysical Properties in the Pleiotropic Effects of Statins

Murphy, C., Deplazes, E., Cranfield, C. G., & Garcia, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228745 · Cited by 109 · see citing works

PoLA/CFPiP/PCS guidelines for the management of dyslipidaemias for family physicians 2016

Banach, M., Jankowski, P., Jóźwiak, J., Cybulska, B., Windak, A., Guzik, T., Mamcarz, A., Broncel, M., & Tomasik, T. (2017) · Archives of Medical Science · doi:10.5114/aoms.2017.64712 · Cited by 86 · see citing works

Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)

Penson, P. E., Bruckert, É., MARAIS, D. P., Reiner, Ž., Pirro, M., Sahebkar, A., Bajraktari, G., Mirrakhimov, E. M., Rizzo, M., Mikhailidis, D. P., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12960 · Cited by 84 · see citing works

Statins—From Fungi to Pharmacy

Sadowska, A. J., Osiński, P., Roztocka, A., Kaczmarz-Chojnacka, K., Zapora, E., Sawicka, D., & Car, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010466 · Cited by 77 · see citing works

Intensive LDL-cholesterol lowering therapy and neurocognitive function

Banach, M., Rizzo, M., Nikolić, D., Howard, G., Howard, V. J., & Mikhailidis (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.11.001 · Cited by 66 · see citing works

Muscle Toxicity of Drugs: When Drugs Turn Physiology into Pathophysiology

Janssen, L., Allard, N. A. E., Saris, C. G. J., Keijer, J., Hopman, M. T. E., & Timmers, S. (2019) · Physiological Reviews · doi:10.1152/physrev.00002.2019 · Cited by 67 · see citing works

Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC

Sharpton, S. R., & Loomba, R. S. (2023) · Hepatology · doi:10.1097/hep.0000000000000278 · Cited by 60 · see citing works

Personalized, Precision, and N-of-One Medicine: A Clarification of Terminology and Concepts

Huang, S., & Hood, L. (2019) · Perspectives in biology and medicine · doi:10.1353/pbm.2019.0036 · Cited by 54 · see citing works

In Vitro Light‐Up Visualization of a Subunit‐Specific Enzyme by an AIE Probe via Restriction of Single Molecular Motion

Zang, T., Xie, Y., Su, S., Liu, F., Chen, Q., Jing, J., Zhang, R., Niu, G., & Zhang, X. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201915783 · Cited by 53 · see citing works

Evaluating bempedoic acid for the treatment of hyperlipidaemia

Penson, P. E., McGowan, M. P., & Banach, M. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1280458 · Cited by 52 · see citing works

Statin-Induced Myopathy: Translational Studies from Preclinical to Clinical Evidence

Camerino, G. M., Tarantino, N., Canfora, I., Bellis, M. D., Musumeci, O., & Pierno, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042070 · Cited by 46 · see citing works

Statin Intolerance

Banach, M., & Mikhailidis, D. P. (2018) · Cardiology Clinics · doi:10.1016/j.ccl.2017.12.004 · Cited by 42 · see citing works

Mitochondrial Effects of Common Cardiovascular Medications: The Good, the Bad and the Mixed

Bețiu, A. M., Noveanu, L., Hâncu, I. M., Lascu, A., Petrescu, L., Maack, C., Elmér, E., & Muntean, D. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113653 · Cited by 41 · see citing works

Unripe Rubus coreanus Miquel Extract Containing Ellagic Acid Regulates AMPK, SREBP-2, HMGCR, and INSIG-1 Signaling and Cholesterol Metabolism In Vitro and In Vivo

Lee, K. H., Jeong, E.-S., Jang, G., Na, J.-R., Park, S., Kang, W. S., Kim, E. S., Choi, H., Kim, J. S., & Kim, S. (2020) · Nutrients · doi:10.3390/nu12030610 · Cited by 39 · see citing works

Risk of Myopathy in Patients in Therapy with Statins: Identification of Biological Markers in a Pilot Study

Camerino, G. M., Musumeci, O., Conte, E., Musaraj, K., Fonzino, A., Barca, E., Marino, M., Rodolico, C., Tricarico, D., Camerino, C., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00500 · Cited by 33 · see citing works

Prosarcopenic Effects of Statins May Limit Their Effectiveness in Patients with Heart Failure

Bielecka-Dabrowa, A. M., Fabiś, J., Mikhailidis, D. P., von Haehling, S., Sahebkar, A., Rysz, J., & Banach, M. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.02.003 · Cited by 30 · see citing works

Research advances in the therapy of metabolic syndrome

Lin, Z., & Sun, L. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1364881 · Cited by 32 · see citing works

Effects of SLCO1B1 and GATM gene variants on rosuvastatin-induced myopathy are unrelated to high plasma exposure of rosuvastatin and its metabolites

Bai, X., Zhang, B., Wang, P., Wang, G., Li, J., Wen, D., Long, X.-Z., Sun, H., Liu, Y., Huang, M., et al. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0013-y · Cited by 31 · see citing works

Technological advances and proteomic applications in drug discovery and target deconvolution: identification of the pleiotropic effects of statins

Banfi, C., Baetta, R., Gianazza, E., & Tremoli, E. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.03.001 · Cited by 31 · see citing works

Drug-Induced Myopathies: A Comprehensive Review and Update

Miernik, S., Matusiewicz, A., & Olesińska, M. (2024) · Biomedicines · doi:10.3390/biomedicines12050987 · Cited by 29 · see citing works

Effects of isolated or combined exposure to sibutramine and rosuvastatin on reproductive parameters of adult male rats

Silva, P. V. E., Borges, C. D. S., Rosa, J. D. L., Pacheco, T. L., Figueiredo, T. M., Leite, G. A. A., Guerra, M. T., Anselmo‐Franci, J. A., Klinefelter, G. R., & Kempinas, W. D. G. (2020) · Journal of Applied Toxicology · doi:10.1002/jat.3955 · Cited by 26 · see citing works

Cell-Permeable Succinate Rescues Mitochondrial Respiration in Cellular Models of Statin Toxicity

Avram, V. F., Chamkha, I., Frostner, E. Å., Ehinger, J. K., Timar, R. Z., Hansson, M. J., Muntean, D. M., & Elmér, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010424 · Cited by 22 · see citing works

Genetic Variations and Frequencies of the Two Functional Single Nucleotide Polymorphisms of SLCO1B1 in the Thai Population

Nakorn, C. N., Waisayarat, J., Dejthevaporn, C., Srisawasdi, P., Wongwaisayawan, S., & Sukasem, C. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00728 · Cited by 21 · see citing works

Low vitamin D does not predict statin associated muscle symptoms but is associated with transient increases in muscle damage and pain

Taylor, B. A., Lorson, L., White, C. M., & Thompson, P. D. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.11.011 · Cited by 20 · see citing works

Facts and ideas on statins with respect to their lipophilicity: a focus on skeletal muscle cells and bone besides known cardioprotection

Švec, A., & Adameová, A. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04621-y · Cited by 19 · see citing works

Ticagrelor and Statin Interaction Induces Rhabdomyolysis and Acute Renal Failure: Case reports and Scoping Review

Kariyanna, P. T., Haseeb, S. O., Chowdhury, Y. S., Jayarangaiah, A., Maryniak, A., Mo, G., Hegde, S., Marmur, J. D., & McFarlane, I. M. (2019) · American Journal of Medical Case Reports · doi:10.12691/ajmcr-7-12-9 · Cited by 20 · see citing works

An overview on nanoplatforms for statins delivery: Perspectives for safe and effective therapy

Etemad, L., Salmasi, Z., Moosavian Kalat, S. A., Moshiri, M., Zamanian, J., Kesharwani, P., & Sahebkar, A. (2023) · Environmental Research · doi:10.1016/j.envres.2023.116572 · Cited by 18 · see citing works

Improvement of Platelet Respiration by Cell–Permeable Succinate in Diabetic Patients Treated with Statins

Avram, V. F., Bînă, A. M., Sima, A. C., Aburel, O. M., Sturza, A., Burlacu, O. N., Timar, R. Z., Muntean, D. M., Elmér, E., & Cretu, O. M. (2021) · Life · doi:10.3390/life11040288 · Cited by 17 · see citing works

Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care

Wiggins, B. S., Backes, J. M., & Hilleman, D. (2022) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2681 · Cited by 17 · see citing works

Genetic polymorphisms in ABCB1 are correlated with the increased risk of atorvastatin-induced muscle side effects: a cross-sectional study

Lalatović, N., Ždralević, M., Antunović, T., & Pantović, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-44792-2 · Cited by 15 · see citing works

Creatine as a Candidate to Prevent Statin Myopathy

Balestrino, M., & Adriano, E. (2019) · Biomolecules · doi:10.3390/biom9090496 · Cited by 13 · see citing works

Effects of Statin Treatment on the Development of Tendinopathy: A Nationwide Population-Based Cohort Study

Kwak, D., Moon, S. J., Park, J. W., Lee, D. H., & Lee, J. I. (2023) · Orthopaedic Journal of Sports Medicine · doi:10.1177/23259671231167851 · Cited by 13 · see citing works

Modulation of heat shock proteins by statins

Forouzanfar, F., Butler, A. E., Banach, M., Barreto, G. E., & Sahbekar, A. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.06.020 · Cited by 13 · see citing works

C/EBP homologous protein deficiency inhibits statin-induced myotoxicity

Kim, W., Lee, C., Han, J.-H., Kim, S.-J., Kim, S. Y., Lim, J. H., Park, K. M., Shin, D. S., & Woo, C.-H. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.11.166 · Cited by 11 · see citing works

Developing In Vitro Models to Define the Role of Direct Mitochondrial Toxicity in Frequently Reported Drug-Induced Rhabdomyolysis

Dayel, F. F. B., Alfirevic, A., & Chadwick, A. E. (2023) · Biomedicines · doi:10.3390/biomedicines11051485 · Cited by 11 · see citing works

Genetic Variation in Statin Intolerance and a Possible Protective Role for UGT1A1

Willrich, M. A. V., Kaleta, E. J., Bryant, S. C., Spears, G. M., Train, L. J., Peterson, S. E., Lennon, V. A., Kopecky, S. L., & Baudhuin, L. M. (2017) · Pharmacogenomics · doi:10.2217/pgs-2017-0146 · Cited by 11 · see citing works

Creatine supplementation does not alter the creatine kinase response to eccentric exercise in healthy adults on atorvastatin

Taylor, B. A., Panza, G. A., Ballard, K. D., White, C. M., & Thompson, P. D. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.05.018 · Cited by 11 · see citing works

Cardiac and skeletal muscle changes associated with rosuvastatin therapy in dystrophic mdx mice

Finkler, J. M. G., de Carvalho, S. C., Neto, H. S., & Marques, M. J. (2019) · The Anatomical Record · doi:10.1002/ar.24341 · Cited by 12 · see citing works

Lipid-lowering Therapies in Myositis

Mizus, M. C., & Tiniakou, E. (2020) · Current Rheumatology Reports · doi:10.1007/s11926-020-00942-3 · Cited by 10 · see citing works

In Vitro Light‐Up Visualization of a Subunit‐Specific Enzyme by an AIE Probe via Restriction of Single Molecular Motion

Zang, T., Xie, Y., Su, S., Liu, F., Chen, Q., Jing, J., Zhang, R., Niu, G., & Zhang, X. (2020) · Angewandte Chemie · doi:10.1002/ange.201915783 · Cited by 10 · see citing works

The Management of Hypercholesterolemia in Patients with Neuromuscular Disorder

Loh, W. J., & Watts, G. F. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01077-9 · Cited by 7 · see citing works

Dynamic urine proteome changes in a rat model of simvastatin-induced skeletal muscle injury

Wei, J., Huan, Y., Heng, Z., Zhao, C., Jia, L., Yu, Y., & Gao, Y. (2022) · Journal of Proteomics · doi:10.1016/j.jprot.2021.104477 · Cited by 7 · see citing works

Understanding the Patient Perception of Statin Experience: A Qualitative Study

Vrablı́k, M., Catapano, A. L., Wiklund, O., Qian, Y., Rane, P. P., Grove, A., & Martin, M. L. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01073-7 · Cited by 6 · see citing works

Intracellular high cholesterol content disorders the clock genes, apoptosis-related genes and fibrinolytic-related genes rhythmic expressions in human plaque-derived vascular smooth muscle cells

Lin, C., Tang, X., Xu, L., Qian, R., Shi, Z., Wang, L., Cai, T., Dong, Y., Fu, W., & Guo, D. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0500-z · Cited by 6 · see citing works

Effect of Vitamin D Analogue on Rosuvastatin-Induced Myopathy in Wistar Rats

Chogtu, B., Ommurugan, B., Thomson, S. R., & Kalthur, S. G. (2020) · The Scientific World JOURNAL · doi:10.1155/2020/4704825 · Cited by 6 · see citing works

Adverse effects of statin therapy: real evidence

Bubnova, M. G. (2019) · Cardiosomatics · doi:10.26442/22217185.2019.1.190264 · Cited by 6 · see citing works

Effects of statins on sarcopenia with focus on mechanistic insights and future perspectives

Zhang, X., Wang, X., Huang, L., Zhou, C., Qian, B., Luo, Z., & Chen, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1669591 · Cited by 5 · see citing works

Interplay of OATP1A/1B/2B1 uptake transporters and ABCB1 and ABCG2 efflux transporters in the handling of bilirubin and drugs

Li, W., Sparidans, R. W., Wang, Y., Martins, M. L. F., de Waart, D. R., van Tellingen, O., Song, J., Lebre, M. C., van Hoppe, S., Wagenaar, E., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116644 · Cited by 5 · see citing works

Diagnostik und Therapie von statinassoziierten Muskelsymptomen

Kassner, U., Grunwald, S. A., Spira, D., Buchmann, N., Bobbert, T., Gazzerro, E., Hollstein, T., Spuler, S., & Steinhagen‐Thiessen, E. (2021) · Der Internist · doi:10.1007/s00108-021-01059-0 · Cited by 5 · see citing works

Gynura procumbens ethanol extract improves vascular dysfunction by suppressing inflammation in postmenopausal rats fed a high-fat diet

Nazri, K. A. A., Saad, Q. H. M., Fauzi, N. M., Buang, F., Jantan, I., & Jubri, Z. (2021) · Pharmaceutical Biology · doi:10.1080/13880209.2021.1970199 · Cited by 5 · see citing works

Vitamin D and SAMS

Bartłomiejczyk, M. A., Penson, P. E., & Banach, M. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-33304-1_14 · Cited by 4 · see citing works

Assessment of bee venom therapy in animal model of statin-induced myopathy

Kader, A. A., Azmy, R. M., Maher, E. A., Sayed, B. B. E., Khalil, A. S., Ghalwash, M., & Mahmoud, M. M. (2019) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-019-0120-9 · Cited by 4 · see citing works

Rationale for the use of metformin and exercise to counteract statin‐associated side effects

Haxhi, J., & Thompson, P. D. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13900 · Cited by 4 · see citing works

Structural basis for simvastatin-induced skeletal muscle weakness associated with type 1 ryanodine receptor T4709M mutation

Weninger, G., Dridi, H., Reiken, S. R., Yuan, Q., Zhao, N., Groom, L. A., Leigh, J., Liu, Y., Tchagou, C., Kang, J., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci194490 · Cited by 3 · see citing works

A mobile health application for patients eligible for statin therapy: app development and qualitative feedback on design and usability

Cao, W., Li, L., Mathur, P., Thompson, J., & Milks, M. W. (2023) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-023-02221-4 · Cited by 3 · see citing works

Molecular Mechanisms Affecting Statin Pharmacokinetics after Bariatric Surgery

Petrinović, M., Majetić, D., Bakula, M., Pećin, I., Vitković, D. F., Deškin, M., Perković, D. T., Bakula, M., Gradišer, M., Bilić-Čurčić, I., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910375 · Cited by 3 · see citing works

Chenodeoxycholic Acid‐Modified Polyethyleneimine Nano‐Composites Deliver Low‐Density Lipoprotein Receptor Genes for Lipid‐Lowering Therapy by Targeting the Liver

Guo, X., Xu, J., Lu, X., Zheng, X., Chen, X., Sun, Z., Shen, B., Tang, H., Duan, Y., Zhou, Z., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400254 · Cited by 2 · see citing works

Genetic Biomarkers for Statin-Induced Myopathy

Prieto-Pena, D., Urriago-Gil, J. D., Ocejo-Vinyals, J. G., García‐Ibarbia, C., Salmón, Z., Martín-Millán, M., Corrales-Selaya, C., Pulito‐Cueto, V., López‐Mejías, R., Blanco, R., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211144 · Cited by 2 · see citing works

The eccentric mechanotransduction, neuro-muscular transmission, and structural reversibility of muscle fatty infiltration. An experimental advanced disuse muscle-wasting model of rabbit supraspinatus

Fabiś, J., Danilewicz, M., Niedzielski, K. R., Waszczykowski, M., Fabiś-Strobin, A., & Bogucki, A. (2021) · Archives of Medical Science · doi:10.5114/aoms/131956 · Cited by 2 · see citing works

Plasma 2-hydroxyglutarate, a promising prognostic biomarker candidate for skeletal muscle injury in Fischer 344 rats

Obayashi, H., Kobayashi, N., Nezu, Y., Yamoto, T., Shirai, M., & Asai, F. (2018) · The Journal of Toxicological Sciences · doi:10.2131/jts.43.601 · Cited by 2 · see citing works

Future of Statins in Sepsis: A Review on Its Safety and Efficacy

eladwy, S., & Bazan, N. S. (2020) · Archives of Pharmaceutical Sciences Ain Shams University · doi:10.21608/aps.2020.2001.1022 · Cited by 2 · see citing works

Management of Statin Intolerance

Bartłomiejczyk, M. A., Penson, P. E., & Banach, M. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56514-5_12 · Cited by 1 · see citing works

Engineered biodegradable polymeric nanoparticles injectable system of atorvastatin for improved therapeutic activity

Venkatraman, R., Narayanan, V. H. B., Nowakowski, S., Nellinger, S., Kluger, P. J., Kopka, B., Brzeziński, M., Sankar, A., & Durai, R. D. (2025) · Scientific Reports · doi:10.1038/s41598-025-31548-3 · Cited by 1 · see citing works

Some molecular mechanisms of the statin-associated myopathy development

Zagayko, A. L., & Брюханова, Т. О. (2017) · Ukrainian biopharmaceutical journal · doi:10.24959/ubphj.17.113 · Cited by 1 · see citing works

Statin Therapy Mitigates Oxidative Stress in Epicardial and Perivascular Adipose Tissue: A Pilot Study in Cardiac Surgery Patients

Brăescu, L. (2024) · Timişoara Medical Journal · doi:10.35995/tmj20240103 · Cited by 1 · see citing works

Mevalonate in blood and muscle: Response to atorvastatin treatment and the relationship to statin intolerance in patients with coronary heart disease

Lauritzen, T., Munkhaugen, J., Bergan, S., Sverre, E., Peersen, K., Lindahl, S., Husebye, E., & Vethe, N. T. (2024) · Clinical and Translational Science · doi:10.1111/cts.70025 · Cited by 1 · see citing works

The insidious impact of under-diagnosed proximal weakness induced by statins

Dobkin, B. H. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1866988 · Cited by 1 · see citing works

Statins in Females

Vanajakshamma, V., Kasala, L., & Chanda, N. (2019) · Indian Journal of Cardiovascular Disease in Women · doi:10.1055/s-0039-1697076

Effects of metabolic syndrome on the correlation between the most common groups of prescribed medications and the risk of fall in Brazilian elderly peoplePreprint

Souza, E. S., Silva, W., & de Vasconcelos, A. T. R. (2020) · doi:10.21203/rs.3.rs-25231/v1

Histological Study for the Effect of Squalene Supplements on Muscles Rats Treated with Simvastatin

Oribi, Z. A., Hassan, M. S., Jawad, M. J., Hassan, M. S., Mohammed, O. A., & Alzaidi, O. H. (2023) · Journal of Kerbala for Agricultural Sciences · doi:10.59658/jkas.v10i2.1189

A critical look at the new possibilities of therapeutic use of statins – a summary of the current state of knowledge

Kossakowski, K., Orzechowska, K., Sikora, W., Grabowska, W., Kowalska, K., Kujawski, R., Czora-Poczwardowska, K., Szulc, M., Mikołajczak, P. Ł., & Bartkowiak-Wieczorek, J. (2023) · Farmacja Polska · doi:10.32383/farmpol/174070

Identifying potential biomarkers for early evaluating mechanical compression injuries to skeletal muscle through proteomic analysis: A rat model

Jia, H., Zhang, H., Liu, Y., Guo, J., Chen, W., Zhang, Y., Scarlat, M. M., Liu, L., & Hou, Z. (2025) · PLoS ONE · doi:10.1371/journal.pone.0324706

Urine Proteome Changes in a Simvastatin-Induced Skeletal Muscle Injury Rat Model

Wei, J., Huan, Y., Heng, Z., & Zhao, C. (2025) · Springer eBooks · doi:10.1007/978-981-96-7886-0_24

Additional file 1 of A mobile health application for patients eligible for statin therapy: app development and qualitative feedback on design and usability

Cao, W., Li, L., Mathur, P., Thompson, J., & Milks, M. W. (2024) · Figshare · doi:10.6084/m9.figshare.26605300

Construction and Validation of a Risk Prediction Model for Statin‐Associated Muscle Symptoms (SAMS) in Atorvastatin Users

Huang, J., Fan, Z., & Ding, Y. (2026) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1155/jcpt/3306258

Protective Effects of N-Acetylcysteine Plus Coenzyme Q10 Combination Against Atorvastatin-Induced Toxicity: Evidence from In Vivo and In Vitro Experimental Models

Hamze, B., Sümer, E., Cumbul, A., Köprülü, E. N., Charehsaz, M., Si̇pahi̇, H., Kassab, I., Dabboussi, F., & Aydın, A. (2026) · Antioxidants · doi:10.3390/antiox15111374

Muscle-related side-effects of statins

Taylor, B. A., & Thompson, P. D. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000174 · Cited by 53 · see citing works

Definitions of Statin-Associated Muscle Symptoms

Rosenson, R. S. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-33304-1_4 · Cited by 1 · see citing works

Statin Myalgia is Detected by a Single Lipid Marker

Laaksonen, R., Tarassov, K., Kauhanen, D., Sylvänne, T., Jänis, M. T., Hurme, R., Ekroos, K., Mombelli, G., Sirtori, C. R., Phillips, M. B., et al. (2012) · Journal of clinical lipidology · doi:10.1016/j.jacl.2012.04.048

Statin-Associated Muscle Symptoms and Myotoxicity: A Clinically Oriented Narrative Review with a Practical Prevention, Evaluation, and Management Algorithm

Epelde, F. (2026) · Medicina · doi:10.3390/medicina62061134 · Cited by 1 · see citing works

Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

Stroes, E. S., Thompson, P. D., Corsini, A., Vladutiu, G. D., Raal, F. J., Ray, K. K., Roden, M., Stein, E., Tokgözoğlu, L., Nordestgaard, B. G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv043 · Cited by 1,443 · see citing works